ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+21.43%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$277M
AUM Growth
+$277M
(-24%)
Cap. Flow
-$56.8M
Cap. Flow
% of AUM
-20.47%
Top 10 Holdings %
Top 10 Hldgs %
45.56%
Holding
64
New
13
Increased
10
Reduced
20
Closed
17
Top Buys
| 1 |
VistaGen Therapeutics
VTGN
|
$10.2M |
| 2 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
$8.58M |
| 3 |
ESSA Pharma
EPIX
|
$8.34M |
| 4 |
Aclaris Therapeutics
ACRS
|
$8.01M |
| 5 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
$7.6M |
Top Sells
| 1 |
Larimar Therapeutics
LRMR
|
$18.5M |
| 2 |
Immunovant
IMVT
|
$13.1M |
| 3 |
Celldex Therapeutics
CLDX
|
$12.6M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$10.3M |
| 5 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$9.24M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 5.21% |
